SGHT Sight Sciences, Inc.

Company profile

• Sector: Healthcare
• Industry: Medical - Devices
• Country: US
• Exchange: NASDAQ
• Employees: 216
• Website: https://www.sightsciences.com

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

Latest SGHT news

• 2026-11-05Sight Sciences signals $92M-$93M 2026 revenue outlook amid higher IDE target of ~$12M Read article
• 2026-11-05Sight Sciences (SGHT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Read article
• 2026-11-04Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates Read article
• 2026-11-04Sight Sciences GAAP EPS of -$0.64 misses by $0.52, revenue of $24.9M beats by $1.39M Read article
• 2026-10-12Sight Sciences, Inc. (NASDAQ:SGHT) Stock Has Consensus Price Target of $8.38 Read article
• 2026-10-09Sight Sciences: Signs Of Progress, But Plenty Of Work Remains Read article

Recent dilution filers

• AIOK — AI OKTO CORP.
• AIRE — reAlpha Tech Corp.
• ANVS — Annovis Bio, Inc.
• ARQT — Arcutis Biotherapeutics, Inc.
• BOSC — B.O.S. Better Online Solutions Ltd.
• CODX — Co-Diagnostics, Inc.

Related companies

• ABT — Abbott Laboratories
• SYK — Stryker Corporation
• MDT — Medtronic plc
• BSX — Boston Scientific Corporation
• EW — Edwards Lifesciences Corporation
• PHG — Koninklijke Philips N.V.